Satoh et al. [61] describes the importance of “phyrymidine biosynthesis” in colorectal cancer, while [62] highlights that loss of “APC expression” in tumor tissue may be related with the risk for recurrence and a poor survival rate for patients with colorectal cancer. Here, APC is linked to neoplasm.